Skip to main content
. 2022 Oct 12;7(5):706–716. doi: 10.1089/can.2021.0058

Table 7.

Comparison of Reported Withdrawal Symptoms Associated with Cannabigerol-Predominant and Non-CBG-Dominant Cannabis (N=127)

Withdrawal symptom % endorsed for CBG-predominant cannabis % endorsed for non-CBG-predominant cannabis Chi-square value p
Sleep difficulties 1.6 9.4 7.40 0.007
Anxiety/nervousness 0.8 7.1 6.62 0.01
Irritability/aggression 0.8 6.3 5.59 0.02
Restlessness 0.8 4.7 3.60 0.06
Depressed mood 0.8 3.9 2.65 0.10
Nightmares/vivid Dreams 0 3.1 3.98 0.046
Nausea 0 1.6 2.04 0.15
Lower appetite/weight loss 0 3.1 3.98 0.046
Panic 0 0.8 1.02 0.31